Zhejiang Cheng Yi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Cheng Yi Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥5.26 Million (capex CN¥5.26 Million ) from operating cash flow of CN¥55.69 Million. Explore Zhejiang Cheng Yi Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
Cash flow reinvestment rate of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. Historical reinvestment intensity for Zhejiang Cheng Yi Pharmaceutical Co Ltd across 15 annual periods. Explore Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2011–2025)
Zhejiang Cheng Yi Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Cheng Yi Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | CN¥56.65 Million | CN¥280.39 Million | CN¥45.40 Million | ▼ -39.7% |
| 2024 | 0.33x | CN¥68.89 Million | CN¥205.72 Million | CN¥59.89 Million | ▼ -20.6% |
| 2023 | 0.42x | CN¥82.10 Million | CN¥194.78 Million | CN¥70.85 Million | ▼ -85.8% |
| 2022 | 2.98x | CN¥494.24 Million | CN¥165.94 Million | CN¥252.85 Million | ▲ +169.6% |
| 2021 | 1.10x | CN¥158.51 Million | CN¥143.49 Million | CN¥134.11 Million | ▼ -35.0% |
| 2020 | 1.70x | CN¥302.05 Million | CN¥177.81 Million | CN¥143.67 Million | ▲ +65.4% |
| 2019 | 1.03x | CN¥185.90 Million | CN¥181.01 Million | CN¥183.81 Million | ▼ -74.9% |
| 2018 | 4.09x | CN¥549.48 Million | CN¥134.30 Million | CN¥271.52 Million | ▼ -11.6% |
| 2017 | 4.63x | CN¥308.84 Million | CN¥66.75 Million | CN¥37.99 Million | ▲ +50.4% |
| 2016 | 3.08x | CN¥292.48 Million | CN¥95.08 Million | CN¥21.63 Million | ▲ +1401.5% |
| 2015 | 0.20x | CN¥16.79 Million | CN¥81.94 Million | CN¥16.79 Million | ▼ -31.1% |
| 2014 | 0.30x | CN¥25.01 Million | CN¥84.11 Million | CN¥25.01 Million | ▼ -39.2% |
| 2013 | 0.49x | CN¥23.57 Million | CN¥48.19 Million | CN¥23.57 Million | ▲ +2.9% |
| 2012 | 0.48x | CN¥18.05 Million | CN¥37.96 Million | CN¥18.05 Million | ▼ -65.4% |
| 2011 | 1.37x | CN¥13.78 Million | CN¥10.04 Million | CN¥13.78 Million | — |